EMA's PRAC Lifts Temporary Restriction On Ixchiq Vaccination For People 65 Years & Older
View all comments(0)
July 11 (Reuters) - EMA:
EMA CONCLUDES REVIEW OF SEMAGLUTIDE MEDICINES AND STARTS REVIEW OF TWO CHICKENPOX VACCINES
IXCHIQ TEMPORARY RESTRICTION ON VACCINATING PEOPLE 65 YEARS AND OLDER TO BE LIFTED
PRAC CONCLUDED IXCHIQ SHOULD ONLY BE GIVEN WHEN THERE IS A SIGNIFICANT RISK OF CHIKUNGUNYA INFECTION & AFTER CONSIDERATION OF BENEFITS & RISKS
PRAC RECOMMENDED UPDATE TO PRODUCT INFORMATION OF VARILRIX AND VARIVAX TO FURTHER DESCRIBE SEVERITY OF RISK OF ENCEPHALITIS
AMENDED PRODUCT INFORMATION OF CHICKENPOX VACCINES WILL GIVE FURTHER DETAIL ON THE KNOWN SIDE EFFECT ENCEPHALITIS
PRAC ASSESSING NEW DATA ON POTENTIAL RISK OF NEURODEVELOPMENTAL DISORDERS IN CHILDREN BORN TO MEN TREATED WITH VALPROATE
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Like
Recommended Articles
Featured Tools
Top News
Cerebras Systems IPO 2026: Date, Price, Valuation, and Whether CBRS Is Worth Buying

April 2026 CPI Preview: Will Hot Inflation Crush Nasdaq, S&P 500 & NVDA? Explosive Market Reaction Guide

'Big Short' Burry Doubles Down: Nvidia, Palantir Short Positions Double in Big Bet on AI Bubble Bursting

Is Micron the Next Nvidia? Why the 2026 "Memory Crunch" Makes MU Stock a Top AI Buy

U.S. April CPI Preview: Fed May Abandon Rate Cuts Until 2026?

Tradingkey








Comments (0)
Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.